News, views and contacts from the global Medical industry

Scientists Develop Blood Test for Fatty Liver Disease

22 September 2010

Scientists from the Basque Center for Cooperative Research in Biosciences (CIC bioGUNE) and OWL Genomics have developed a blood test for non-alcoholic fatty liver disease.

Non-alcoholic fatty liver disease is a progressive disease that can range from a simple accumulation of fat in the liver (steatosis) to a severe liver condition known as non-alcoholic steatohepatitis.

The test is based on metabolomics technology and can distinguish simple steatosis from non-alcoholic steatohepatitis.

Scientists used a genetically modified mouse model to identify the biomarkers of non-alcoholic fatty liver disease they shared with humans.

They then analysed the blood samples of steatosis and non-alcoholic steatohepatitis patients to identify the biomarkers that can distinguish between the two liver conditions.

OWL Genomics has initiated the commercialisation of the test in Spain.